Inventor
COLLINGWOOD STEPHEN PAUL
GB27 patents
⚠️ This page may combine multiple inventors who share the name “COLLINGWOOD STEPHEN PAUL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS AG
10 patentsUS6589950B1Jul 8, 2003
Purine derivatives inhibitors of tyrosine protein kinase SYK
NOVARTIS AG106 citations95
US7947730B2May 24, 2011
Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic M3 receptor
NOVARTIS AG7 citations84
US8039472B2Oct 18, 2011
Pyrazine-2-carboxamide derivatives to treat diseases mediated by blockade of the epithelial sodium channel
NOVARTIS AG8 citations82
US6087490AJul 11, 2000
Dinucleotide and oligonucleotide analogues
NOVARTIS AG16 citations82
US5670489ASep 23, 1997
Oligonucleotide analogues
NOVARTIS AG12 citations71
US6919337B2Jul 19, 2005
8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors
NOVARTIS AG9 citations69
US7803804B2Sep 28, 2010
Substituted pyrazines for use in the treatment of inflammatory or allergic conditions
NOVARTIS AG6 citations62
US7723356B2May 25, 2010
Quinuclidine derivatives and their use as muscarinic m3 receptor antagonists
NOVARTIS AG3 citations60
US7019136B2Mar 28, 2006
8-quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors
NOVARTIS AG0 citations50
US9751876B2Sep 5, 2017
Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
NOVARTIS AG0 citations48
RESPIVERT LTD
3 patentsUS11208381B2Dec 28, 2021
Indole derivatives and their use as protein kinase inhibitors
RESPIVERT LTD2 citations70
US10669235B2Jun 2, 2020
Indole derivatives and their use as protein kinase inhibitors
RESPIVERT LTD2 citations70
US11046672B2Jun 29, 2021
Indolinones compounds and their use in the treatment of fibrotic diseases
RESPIVERT LTD0 citations46
BHALAY GURDIP
3 patentsUS9139586B2Sep 22, 2015
Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives
BHALAY GURDIP2 citations59
US8697687B2Apr 15, 2014
Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives
BHALAY GURDIP2 citations59
US9643983B2May 9, 2017
Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives
BHALAY GURDIP0 citations48
ISIS PHARMACEUTICALS INC
2 patentsCOLLINGWOOD STEPHEN PAUL
2 patentsUS8664228B2Mar 4, 2014
3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of airway diseases
COLLINGWOOD STEPHEN PAUL7 citations81
US8236808B2Aug 7, 2012
Pyrazine derivatives as ENAC blockers
COLLINGWOOD STEPHEN PAUL21 citations80